NCT03017599 is a NA clinical trial of 20-gauge ProCore FNB needle in Pancreatic Cancer, sponsored by Yonsei University.

Who is sponsoring NCT03017599?

NCT03017599 is sponsored by Yonsei University.

What drugs are being tested in NCT03017599?

Interventions in NCT03017599: 20-gauge ProCore FNB needle.

What condition does NCT03017599 study?

NCT03017599 studies Pancreatic Cancer, Solid Pancreatic and Peripancreatic Lesion.

Is NCT03017599 still recruiting?

NCT03017599 is currently completed. Last updated 22 May 2018.

Last reviewed 2018-05-22 · How we verify

NCT03017599

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Yield Rate for Procurement the Histologic Core With Endoscopic Ultrasound-guided Fine Needle Biopsy With 20-gauge Ultrasound Biopsy Needles for Solid Pancreatic Masses: Pilot Study

Completed NA Last updated 22 May 2018

What this trial tests

NA trial testing 20-gauge ProCore FNB needle in Pancreatic Cancer in 30 participants. Completed in 10 July 2017.

Timeline

11 July 2016

Primary endpoint
10 July 2017

10 July 2017

Quick facts

Lead sponsor	Yonsei University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	30
Start date	11 July 2016
Primary completion	10 July 2017
Estimated completion	10 July 2017
Sites	1 location across South Korea

Drugs / interventions tested

20-gauge ProCore FNB needle

Conditions studied

Pancreatic Cancer — all drugs for Pancreatic Cancer →
Solid Pancreatic and Peripancreatic Lesion — all drugs for Solid Pancreatic and Peripancreatic Lesion →

Sponsor

Yonsei University

Who can join

20 and older, any sex, with Pancreatic Cancer or Solid Pancreatic and Peripancreatic Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the technical feasibility and diagnostic yield of new 20-gauge Procore needle for EUS-guided fine needle biopsy in pancreatic solid lesions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Establishment of pancreatic cancer cell lines with endoscopic ultrasound-guided biopsy via conditionally reprogrammed cell culture.
Lee HS, Lee JS, Lee J, Kim EK, et al · · 2019 · cited 10× · PMID 31044541 · DOI 10.1002/cam4.2210

Verify or expand the search:

Other recruiting trials for Pancreatic Cancer

Currently open trials in the same condition.

NCT07126158 — Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma · Phase 2 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
NCT07409272 — A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherap · Phase 3 · recruiting
NCT07236177 — B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosi · EARLY_PHASE1 · recruiting

Other Yonsei University trials

Trials by the same sponsor.

NCT07547592 — Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Soft Tissue Sarcoma · Phase 2 · not yet recruiting
NCT07524101 — Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD · NA · not yet recruiting
NCT07506629 — Adductor Canal Block Methods in Bilateral Total Knee Arthroplasty · NA · not yet recruiting
NCT07515716 — Effects of High Flow Humidified Oxygen on Umbilical Artery Acid-base Balance in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07507188 — Collaborative Clinical-translational Cohort of Amivantamab Plus Lazertinib and Amivantamab Plus Chemotherapy in Patients · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03017599 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yonsei University
Last refreshed: 22 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03017599.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing